ContractNavidea Biopharmaceuticals, Inc. • July 31st, 2012 • In vitro & in vivo diagnostic substances
THIS PROMISSORY NOTE IS SUBJECT TO THE PROVISIONS OF A SUBORDINATION AGREEMENT DATED ON OR ABOUT THE DATE HEREOF BY AND AMONG THE LENDER, HERCULES TECHNOLOGY II, L.P., AND THE BORROWER
LOAN AGREEMENT dated as of July 25, 2012 BETWEEN Navidea Biopharmaceuticals, Inc., As Borrower and Platinum-Montaur Life Sciences LLC, As LenderLoan Agreement • July 31st, 2012 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • New York
This Loan Agreement (as amended, restated, supplemented or otherwise modified, this “Agreement”) is entered into between Platinum-Montaur Life Sciences LLC, a Delaware limited liability company with its principal place of business at 152 West 57th Street, 4th Floor, New York, NY 10019 (together with its successors, “Lender”), and Navidea Biopharmaceuticals, Inc., a Delaware corporation with its principal place of business at 425 Metro Place North, Suite 450, Dublin Ohio 43017 (together with its successors, “Borrower”), as of the ___ day of July, 2012 (the “Effective Date”).
